WWOX and breast cancer: For luminal breast cancers, we found that high WWOX/HIF1A ratios demonstrate a more robust anti-tumour immune response, as evidenced by increased expression of CD8A and FOXP3, which are instrumental in recruiting cytotoxic T-cells and suppressing pro-tumourigenic inflammation [151,152].